Stockscreener 앱 받기
7.92
0.63%
-0.05
시간 외 거래:
7.92
전일 마감가:
$7.97
열려 있는:
$7.93
하루 거래량:
16,625
Relative Volume:
0.38
시가총액:
$109.23M
수익:
$49.98M
순이익/손실:
$-9.64M
주가수익비율:
-11.15
EPS:
-0.71
순현금흐름:
$-4.86M
1주 성능:
+0.25%
1개월 성능:
-17.33%
6개월 성능:
+76.00%
1년 성능:
+56.52%
1일 변동 폭
$7.74
$8.44
1주일 범위
$7.74
$8.8564
52주 변동 폭
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
명칭
Champions Oncology Inc
전화
410-369-0365
주소
855 N. WOLFE STREET, BALTIMORE, NJ
CSBR을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
7.92 | 109.23M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
477.52 | 127.47B | 11.02B | -535.60M | -978.00M | -2.20 |
|
REGN
Regeneron Pharmaceuticals Inc
|
561.49 | 62.43B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
595.70 | 37.03B | 2.19B | 833.04M | -1.28B | 12.71 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
232.75 | 31.06B | 2.25B | -278.16M | -42.59M | -2.17 |
|
ONC
Beigene Ltd Adr
|
229.22 | 26.16B | 3.81B | -644.79M | -669.77M | -6.24 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-09-12 | 업그레이드 | Craig Hallum | Hold → Buy |
| 2019-11-18 | 개시 | The Benchmark Company | Speculative Buy |
Champions Oncology Inc 주식(CSBR)의 최신 뉴스
Press Release Distribution & PR Platform - ACCESS Newswire
Champions Oncology's (NASDAQ:CSBR) investors will be pleased with their respectable 47% return over the last year - Yahoo
I-Apollo Hospitals, yethula i-“Cancer Champions United” isinyathelo esiyingqayizivele sokunikeza amandla Abasinde Ngomdlavuza! - Apollo Hospitals
Patient Derived Xenograft Model Market Future Business - openPR.com
Champions Oncology Reports Record Quarterly Revenue of $7.7 Million For The Fourth Quarter Ended April 30, 2019 - ACCESS Newswire
Investors Give Champions Oncology, Inc. (NASDAQ:CSBR) Shares A 28% Hiding - simplywall.st
Apollo Hospitals, yakhazikitsa "Cancer Champions United" njira yapadera yopatsa mphamvu Opulumuka Khansa! - Apollo Hospitals
How To Trade (CSBR) - news.stocktradersdaily.com
Pre-market Movers: PTPI, ACON, HUMA, TNON... - RTTNews
CHAMPIONS ONCOLOGY, INC. SEC 10-Q Report - TradingView
Champions Oncology Third Quarter 2025 Earnings: EPS: US$0.33 (vs US$0.19 loss in 3Q 2024) - Yahoo Finance
Champions Oncology target raised to $12 at Craig-Hallum By Investing.com - Investing.com Canada
Champions Oncology, Inc. (NASDAQ:CSBR) Q3 2025 Earnings Call Transcript - MSN
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations By Investing.com - Investing.com South Africa
Champions Oncology Achieves Record Revenue and Profit - TipRanks
Champions Oncology earnings beat by $0.37, revenue topped estimates - Investing.com Canada
Earnings call transcript: Champions Oncology Q1 2025 earnings beat expectations - Investing.com
CHAMPIONS ONCOLOGY Earnings Results: $CSBR Reports Quarterly Earnings - Nasdaq
Champions Oncology stock surges as earnings beat expectations By Investing.com - Investing.com South Africa
Champions Oncology stock surges as earnings beat expectations - Investing.com India
Champions Oncology Reports Record Quarterly Revenue and Net Income - TradingView
Champions Oncology Reports Record Quarterly Revenue of $17.0 Million Record Net Income of $4.5 Million - ACCESS Newswire
Stock Index Futures Gain After Yesterday’s Selloff, U.S. JOLTs Report in Focus - TradingView
Earnings Scheduled For March 11, 2025 - Benzinga
CHAMPIONS ONCOLOGY Earnings Preview: Recent $CSBR Insider Trading, Hedge Fund Activity, and More - Nasdaq
Champions Oncology Inc expected to post a loss of 1 cent a shareEarnings Preview - TradingView
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 11, 2025 - ACCESS Newswire
When Will Champions Oncology Report Q3 Results? Key Date for Oncology Research Leader - StockTitan
(CSBR) Technical Pivots with Risk Controls - Stock Traders Daily
mPATH Health Triumphs with Double Recognition for Excellence in Cancer Care - PR Newswire
Targeted Oncology Adds The Florida Society of Clinical Oncology to Its Strategic Alliance Partnership Program - Florida Trend
CSBR stock hits 52-week high at $10.91 amid robust growth - MSN
We're Interested To See How Champions Oncology (NASDAQ:CSBR) Uses Its Cash Hoard To Grow - Yahoo Finance
Galleri Classic: Fred Couples, Ernie Els, Vijay Singh commit to play - firstcallgolf.com
Champions Oncology Reports Quarterly Revenue of $6.7 Million - ACCESS Newswire
Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Monday, July 24, 2023 - ACCESS Newswire
ZERO Advocacy Summit Ignites National Movement for Prostate Cancer Reform, Rallying Patients, Survivors, and Policymakers on Capitol Hill - Yahoo Finance
Champions Oncology Reports Record Quarterly Revenue of $9.5 Million - ACCESS Newswire
Champions Oncology, Inc. to Host Earnings Call - ACCESS Newswire
Champions Oncology Reports Quarterly Revenue of $7.6 Million - ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $11.3 Million - ACCESS Newswire
Champions Oncology (NASDAQ:CSBR) pulls back 16% this week, but still delivers shareholders notable 57% return over 1 year - Simply Wall St
CSBRChampions Oncolo Latest Stock News & Market Updates - StockTitan
Champions Oncology to Announce Fourth Quarter Financial Results on Thursday, July 21, 2022 - ACCESS Newswire
Champions Oncology Reports Record Quarterly Revenue of $10.8 Million - ACCESS Newswire
Prospect High students champions in fight against blood cancer - Daily Herald
Champions Oncology to Announce Third Quarter Financial Results on Thursday, March 11, 2021 - ACCESS Newswire
Champions Oncology Announces 17 Abstracts Accepted for Presentation at the 2025 American Association for Cancer Research Annual Meeting - ACCESS Newswire
Revolutionary Cancer Research Alert: Champions Oncology Unveils 17 Game-Changing Studies at AACR 2025 - StockTitan
CancerX Launches 2025 Accelerator to Drive Innovation in Oncology - Business Wire
Flow Cytometry Market Size to Worth USD 12.11 Billion by 2034 - GlobeNewswire
Champions Oncology Inc (CSBR) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.15%
4.32%
자본화:
|
볼륨(24시간):